This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Walgreens Offering Free Plan Reviews, Other Services To Help Medicare Beneficiaries As Annual Election Period Begins Oct. 15

Stocks in this article: WAG

With this year’s Medicare Annual Election Period overlapping with the unrelated open enrollment for the new federal and state insurance marketplaces, there’s a growing need to help Medicare beneficiaries understand their health care coverage options when Medicare open enrollment begins tomorrow. Walgreens (NYSE: WAG) (Nasdaq: WAG) pharmacists will serve as one of the most convenient and accessible resources for Medicare Part D information, offering free, personalized plan comparison reports at every location, every day, to help beneficiaries evaluate the plans that may best meet their prescription drug needs.

Walgreens prescription plan comparison report details each plan’s estimated annual costs, including monthly premiums, brand and generic co-pays and drugs covered through the coverage gap (donut hole). Walgreens pharmacists will review the report to help Medicare beneficiaries understand their coverage options, as well as the latest information on Medicare, whether they’re selecting a plan for the first time or evaluating if their current plan is still the best option. Plan reviews will be available on a walk-in basis or by scheduling an appointment at www.walgreens.com/medicare.

Walgreens is a part of Medicare preferred pharmacy networks with four national Part D plan sponsors -Coventry Health Care, Humana, UnitedHealthcare and WellCare. The preferred networks are designed to offer Medicare beneficiaries additional options to save on their prescription drugs.

Cost savings remains top of mind for many Medicare beneficiaries, as more than one-third of those surveyed 1 (37 percent) are concerned about prescription drug costs, and 1-in-5 say they’ve made sacrifices, such as delaying filling a prescription or skipping doses to help manage medication costs.

“Many Medicare beneficiaries don’t fully understand certain aspects of their health plan, including cost savings options, and some also become non-adherent to medication therapies as a way to try to reduce costs,” said Suzanne Hansen, Walgreens group vice president of pharmacy operations. “The Medicare environment can be challenging to navigate, and we anticipate an even greater need to help educate our customers this year, given the changes that are taking place across the health care landscape. Walgreens, as a preferred network provider, offers a number of benefits, which may include savings of up to 75 percent on prescription co-pays and our pharmacists are trusted experts who can help beneficiaries understand their plan options.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs